首页 | 本学科首页   官方微博 | 高级检索  
     


Histone methylation antagonism drives tumor immune evasion in squamous cell carcinomas
Affiliation:1. Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY 10032, USA;2. Department of Urology, Columbia University Irving Medical Center, New York, NY 10032, USA;3. Department of Human Genetics, McGill University, Montreal, QC H3A 1B1, Canada;4. McGill University Genome Centre, Montreal, QC H3A 0G1, Canada;5. Institute for Cancer Genetics, Columbia University Irving Medical Center, New York, NY 10032, USA;6. Department of Pediatrics, Columbia University Irving Medical Center, New York, NY 10032, USA;7. Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA;8. Department of Medicine, Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, NY 10032, USA;9. Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY 10032, USA;10. Division of Digestive and Liver Diseases, Department of Medicine, Columbia Center for Human Development, Columbia University Irving Medical Center, New York, NY 10032, USA;11. Division of Oral and Maxillofacial Pathology, Columbia University College of Dental Medicine and Department of Pathology & Cell Biology, Columbia University Irving Medical Center, New York, NY 10032, USA;12. Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada;13. Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada
Abstract:
><ol class=
  • Download : Download high-res image (157KB)
  • Download : Download full-size image
  • Keywords:epigenetics  histone methylation  DNA methylation  EZH2  NSD1  squamous cell carcinomas  head and neck cancers  immune evasion  Tazemetostat
    本文献已被 ScienceDirect 等数据库收录!
    设为首页 | 免责声明 | 关于勤云 | 加入收藏

    Copyright©北京勤云科技发展有限公司  京ICP备09084417号